Related references
Note: Only part of the references are listed.Fibulin-4 Deficiency Results in Ascending Aortic Aneurysms A Potential Link Between Abnormal Smooth Muscle Cell Phenotype and Aneurysm Progression
Jianbin Huang et al.
CIRCULATION RESEARCH (2010)
TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions
Harry C. Dietz
JOURNAL OF CLINICAL INVESTIGATION (2010)
RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer
Cory Iverson et al.
CANCER RESEARCH (2009)
Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway
Delphine Gomez et al.
JOURNAL OF PATHOLOGY (2009)
The Extracellular Matrix: Not Just Pretty Fibrils
Richard O. Hynes
SCIENCE (2009)
New regulatory mechanisms of TGF-β receptor function
Jong Seok Kang et al.
TRENDS IN CELL BIOLOGY (2009)
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β
Motozo Yamashita et al.
MOLECULAR CELL (2008)
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Matt K. Lee et al.
EMBO JOURNAL (2007)
Mediating ERK1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome
Tomoki Nakamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states
Ronald D. Cohn et al.
NATURE MEDICINE (2007)
Aneurysm syndromes caused by mutations in the TGF-β receptor
Bart L. Loeys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase
K Yoshimura et al.
NATURE MEDICINE (2005)
Aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan's syndrome
R Purnell et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2005)
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
BL Loeys et al.
NATURE GENETICS (2005)
Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK:: a mechanism for activation of latent TGF-β1
T Naito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
T Araki et al.
NATURE MEDICINE (2004)
Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome
DP Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
ER Neptune et al.
NATURE GENETICS (2003)
Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein
Z Isogai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice
XL Xu et al.
ONCOGENE (2000)
Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells
N Fukuda et al.
AMERICAN JOURNAL OF HYPERTENSION (2000)
Share Paper
